Petition Candidate For ACS President-Elect Post - C&EN Global

E. Ann Nalley, professor of chemistry at Cameron University, Lawton, Okla., and District V ACS director, will stand as a petition candidate in this fa...
0 downloads 0 Views 488KB Size
NEWS OF THE WEEK SCIENCE

CONTROLLED PROTEIN SPLICING New chemical genetics technique may allow editing of any protein sequence

I

N THE INCREASINGLY ACTIVE

field ofchemical genetics, small organic molecules are used to alter the function of proteins. Chemical genetics has generally involvedfindingcompounds that affect proteins by binding to them or by causing changes in protein conformation. Researchers have now devised a third form of chemical genetics, in which small molecules influence the function of proteins by changing their sequence. The compounds do this by initiating protein splicing— a process in which the primary sequence of a precursor protein is edited by removal of an internal segment. The new technique was developed by postdoc Henning D. Mootz and professor and lab head Tom W. Muir of the synthetic protein chemistry lab at Rockefeller University \J. Am. Chem. Soc, published online July 11, http://dx.doi.org/10. 1021/ja026769o]. Potential applications include syntheses of toxic, oncogenic, or therapeutic proteins from premade precursors at desired points in time. The approach might also be used to study signal transduction processes. "Protein splicing has great potential for controlling protein function since the process results in a dramatic change in protein sequence, which is intimately linked to function," Muir tells C&EN. "The problem has been that protein splicing is not naturally regulated—it is a spontaneous process, which prevents it being exploited for protein regulation. It is this shortcoming that HTTP://PUBS.ACS.ORG/CEN

we have addressed in this paper." In the new technique, each of two protein fragments is derivatized with a protein-splicing construct—one-half of an "intein"

has to be identified either by screening or rational design for every new protein of interest," Muir says. "We believe this difference is quite significant and will make our approach extremely useful for studying and manipulating protein function both in vitro and in vivo." It's "a very clean and beautiful study on a model protein, showing that the idea works," comments Timothy P. Clackson, senior vice president of science and technology at Ariad Pharmaceuticals. "The key next

THE SPLICE IS RIGHT Small-molecule dimerizer ligand triggers protein-editing process

FKBP C

Y

J FRB

N

lntein L + ^ lnteinc

Q523EÛ

Q2Q3D

Protein X Protein Y

NOTE: FKBP and FRB are ligand-binding proteins.

linked to a protein that can bind a dimerizer ligand. An intein is an intervening protein domain that pops spontaneously out of any protein in which it's found, causing the flanking protein fragments (exteins) to become joined through a conventional peptide bond. A dimerizer is a matchmaking bifunctional ligand that can cross-link two ligand-binding proteins. The method is a hybrid of protein trans-splicing and ligand-induced dimerization, techniques introduced earlier by other groups. When Mootz and Muir introduced the ligand rapamycin to a model system, the ligand induced dimerization, the intein halves combined, the intein popped out, and two protein fragments were joined. In theory, the technique could be used to edit the sequence of any protein, since inteins are happy to pop out ofany set ofexteins. "This should be contrasted with most other chemical genetics approaches, where a new molecule

stage will be to move this into a cell. If you can show that this chemistry and biochemistry functions in the very complex environment of the intracellular milieu, then it really will be a potentially useful genetic tool. The likelihood is that that will be possible."-STU BORMAN ELECTION

Petition Candidate For ACS President-Elect Post Ann Nalley, professor of chemistry at Cameron University, Lawton, Okla., and District VACS dii rector, will stand as a petition candidate in this fall's election for 2003 ACS president-elect. As previously reported, Charles P. Casey, professor of chemistry at the University of Wisconsin, Madison, and Alvin L Kwiram, professor of chemistry and vice provost emeritus at the University of Washington, Seattle, will also run and are the candidates chosen by the ACS Committee on Nominations & Elections and the ACS Council (C&EN, April 15, page 16). The winner will serve as ACS president in 2004 and as a member of the ACS Board from 2003 to 2005. Candidates' statements will appear in C&EN on Sept. 16.

EJ

C&EN / J U L Y 22. 2002

11